Masashi Narazaki, Giovanna Tosato. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Angiogenesis Inhibitors/pharmacologyAngiogenesis Inhibitors/therapeutic useAnimalsAntibodies, Monoclonal/pharmacologyAntibodies, Monoclonal, HumanizedBevacizumabEndothelial Cells/metabolismGene Expression Regulation, Neoplastic/drug effectsHumansMicrocirculation/drug effectsNecrosisNeoplasms/blood supplyNeovascularization, Pathologic/drug therapyNeovascularization, Pathologic/prevention & controlRecombinant Fusion Proteins/pharmacologyVascular Cell Adhesion Molecule-1/drug effects
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedRecombinant Fusion ProteinsVascular Cell Adhesion Molecule-1Bevacizumab
Year: 2005 PMID: 15900035 DOI: 10.1093/jnci/dji152
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506